BeStock  
Stocks › Biotechnology › KOD

Kodiak Sciences KOD

US equityMarket cap rank #1807Biotechnology
$97.17 −$0.73 (-0.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $97.26 +0.09%
Open$97.00
Prev close$97.90
Day range$96.53 – $100.89
Volume693.1K
Market cap$6.35B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$67.10M-7.6% YoY
Net profit-$66.22M-7.8% YoY
Diluted EPS-$1.05+9.5% YoY
Free cash flow-$45.85M-39.2% YoY
Operating cash flow-$43.87M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-44.1MDec '24$-57.5MMar '25$-54.3MJun '25$-61.5MSep '25$-56.7MDec '25$-58.2MMar '26$-65.6MJun '26$-66.2MSep '26

Diluted EPS by quarter

-0.84Dec '24-1.09Mar '25-1.03Jun '25-1.16Sep '25-1.04Dec '25-0.94Mar '26-1.05Jun '26-1.05Sep '26

Free cash flow by quarter

$-30.2MDec '24$-29.3MMar '25$-34.8MJun '25$-32.9MSep '25$-39.4MDec '25$-41.0MMar '26$-46.6MJun '26$-45.8MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-1,360.9%
Return on assets-115.4%
Return on invested capital-346.6%
Current ratio1.70
Liabilities / assets94.0%
Cash & investments$88.68M
Total debt$41.28M
Net cash (debt)$47.40M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $67.10M $66.84M $59.78M $234.39M $57.45M
Selling and Admin Expenses $8.79M $10.76M $11.23M $52.02M $11.96M
-General & Admin Expense $8.79M $10.76M $11.23M $52.02M $11.96M
Research & Development $58.30M $56.08M $48.55M $182.37M $45.49M
Operating Profit -$67.10M -$66.84M -$59.78M -$234.39M -$57.45M
Net Non-Operating Interest Income (Expense) $899,000.00 $1.26M $1.64M $4.52M $757,000.00
Non-Operating Interest Income $899,000.00 $1.26M $1.64M $4.52M $757,000.00
Other Income (Expense) -$24,000.00 -$60,000.00 -$22,000.00 -$96,000.00 -$40,000.00
Other Non-Operating Income (Expenses) -$24,000.00 -$60,000.00 -$22,000.00 -$96,000.00 -$40,000.00
Pretax Profit -$66.22M -$65.64M -$58.16M -$229.97M -$56.74M
Net Profit -$66.22M -$65.64M -$58.16M -$229.97M -$56.74M
Profit from Continuing Operations -$66.22M -$65.64M -$58.16M -$229.97M -$56.74M
Net Income to Parent Company -$66.22M -$65.64M -$58.16M -$229.97M -$56.74M
Net Income to Common Stockholders -$66.22M -$65.64M -$58.16M -$229.97M -$56.74M
Basic EPS -$1.05 -$1.05 -$0.94 -$4.32 -$1.04
Diluted EPS -$1.05 -$1.05 -$0.94 -$4.32 -$1.04
Non-Operating Interest Expense – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $209.41M $256.81M $306.01M $351.53M $351.53M
Total Current Assets $92.89M $131.36M $175.26M $214.82M $214.82M
Cash and Cash Equivalents & Short-Term Investments $88.68M $125.90M $169.53M $209.86M $209.86M
-Cash and Cash Equivalents $88.68M $125.90M $169.53M $209.86M $209.86M
Other Current Assets $4.21M $5.46M $5.73M $4.95M $4.95M
Total Non-Current Assets $116.53M $125.45M $130.75M $136.72M $136.72M
Net PPE $103.65M $110.61M $115.89M $121.86M $121.86M
-Gross PPE $103.65M $110.61M $115.89M $181.34M $181.34M
Other Non-Current Assets $12.88M $14.85M $14.86M $14.85M $14.85M
Total Liabilities $196.84M $195.72M $193.91M $194.15M $194.15M
Total Current Liabilities $54.74M $52.77M $49.57M $45.53M $45.53M
Payables $16.86M $12.64M $11.34M $12.86M $12.86M
-Accounts Payable $16.86M $12.64M $11.34M $12.86M $12.86M
Current Accrued Expenses $32.59M $30.32M $26.57M $20.61M $20.61M
Short-Term Debt and Capital Lease Obligation $5.29M $9.81M $11.66M $12.06M $12.06M
-Current Capital Lease Obligation $5.29M $9.81M $11.66M $12.06M $12.06M
Total Non-Current Liabilities $142.10M $142.95M $144.33M $148.62M $148.62M
Long Term Debt and Capital Lease Obligation $41.28M $42.95M $44.33M $47.12M $47.12M
-Long Term Capital Lease Obligation $41.28M $42.95M $44.33M $47.12M $47.12M
Other Non-Current Liabilities $100.83M $100.00M $100.00M $101.50M $101.50M
Total Equity $12.57M $61.10M $112.10M $157.38M $157.38M
Stockholders' Equity $12.57M $61.10M $112.10M $157.38M $157.38M
Capital Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.76B $1.74B $1.73B $1.72B $1.72B
Retained Earnings -$1.75B -$1.68B -$1.62B -$1.56B -$1.56B
-Accumulated Depreciation – – – -$59.47M -$59.47M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$43.87M -$46.24M -$40.01M -$136.01M -$39.38M
Net cash flow from continuing operations -$43.87M -$46.24M -$40.01M -$136.01M -$39.38M
Net Income from Continuing Operations -$66.22M -$65.64M -$58.16M -$229.97M -$56.74M
Depreciation & Depletion & Amortization $4.86M $6.19M $6.34M $26.32M $6.52M
Change in Working Capital $6.60M $1.61M -$346,000.00 $6.85M -$2.45M
-Change in Prepaid Assets -$558,000.00 $340,000.00 -$975,000.00 $609,000.00 -$1.06M
-Change in Payables and Accrued Expense $7.80M $4.49M $3.83M $17.34M $1.62M
-Change in Other Current Assets $6,000.00 $15,000.00 -$8,000.00 $59,000.00 $6,000.00
-Change in Other Current Liabilities -$647,000.00 -$3.24M -$3.19M -$11.17M -$3.02M
Net cash flow from investing -$1.98M -$352,000.00 -$942,000.00 -$506,000.00 -$43,000.00
Net Cash Flow from Continuing Investing Activities -$1.98M -$352,000.00 -$942,000.00 -$506,000.00 -$43,000.00
Net PPE Purchase and Sale -$1.98M -$352,000.00 -$942,000.00 -$506,000.00 -$43,000.00
Financing Cash Flow $6.38M $2.96M $619,000.00 $178.30M $177.25M
Net Cash Flow from Continuing Financing Activities $6.38M $2.96M $619,000.00 $178.30M $177.25M
Proceeds from Stock Option Exercised $6.49M $2.86M $922,000.00 $5.34M $4.29M
Net Other Financing Charges $0.00 $0.00 -$303,000.00 – –
Ending Cash Balance $92.62M $132.09M $175.71M $216.05M $216.05M
Net Change in Cash -$39.46M -$43.63M -$40.33M $41.79M $137.82M
Beginning Cash Balance $132.09M $175.71M $216.05M $174.26M $78.22M
Free Cash Flow -$45.85M -$46.59M -$40.95M -$136.51M -$39.42M
Other Non-Cash Items – – – $20,000.00 –
Net Investment Purchase and Sale – – – $0.00 $0.00
Net Common Stock Issuance – – – $172.96M –

Discussion

No comments yet — be the first to weigh in on KOD.

Sign in to join the discussion.

Scroll to Top